Quality by design (QbD) refers to the achievement of certain predictable quality with desired and predetermined specifications. A very useful component of the QbD is the understanding of factors and their interaction effects by a desired set of experiments by using software (design expert 8). The present study describes the development of a comprehensive science and risk based HPLC method which is given by design expert 8 and subsequent validation for the analysis of Efavirenz active pharmaceutical ingredient (API) using a quality by design approach. An efficient experimental design based on systematic scouting of all four key components of the RP-HPLC method (column, pH, mobile phase and flow rate) is presented. The described method was linear. R 2 =0.9998. The precision, ruggedness and robustness values were also within the prescribed limits (<1% for system precision and <2% for other parameters). Chromatographic peak purity results indicated the absence of co-eluting peaks with the main peak of Efavirenz. The proposed method can be used for routine analysis of Efavirenz in quality control laboratories.
INTRODUCTION

Introduction to Drug Molecule
Chemically efavirenz is (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one. It has molecular formula of C14H9ClF3NO2. It is crystalline powder having white or slightly yellowish colour. The melting point of Efavirenz is ranging from 136.0 0 C to 141.0 0 C. Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). Efavirenz is directly connected to the enzyme and blocks the enzyme catalytic site. It is used as a part of highly active antiretroviral therapy for the treatment of human immunodeficiency virus. The drug is used in combination with other anti-retroviral agents for the treatment of HIV-1 infection in children's and adults. The usual dosage of efavirenz is 600mg per day. It is usually taken on empty stomach at bedtime to reduce neurological and psychiatric adverse effects. Structure of efavirenz is given in Figure no 1. 1
Quality by Design (QbD) is a concept first outlined by
Juran in various publications. Juran believed that quality could be planned and that most quality crises and problems relate to the way in which quality was planned in the first place. Experimental design (DoE), as a tool of QbD, can be defined as the strategy for setting up experiments in such a manner that the information required is obtained as efficiently and precisely as possible. Experimental design (DoE) is a powerful technique used for exploring new processes, gaining increased knowledge of the existing processes and optimizing these processes for achieving world-class performance. Experimentation is performed to determine the relationship between factors acting on the response. The potential benefits of using a DoE rather than using traditional "one factor at a time" experimentation are summarized below: Full three-level factorial design is an experimental matrix that has limited application in RSM when the factor number is higher than 2 because the number of experiments required for this design (calculated by expression N = 3k, where N is experiment number and k is factor number) is very large, thereby losing its efficiency in the modelling of quadratic functions. Because a complete three-level factorial design for more than two variables requires more experimental runs than can usually be accommodated in practice, designs that present a smaller number of experimental points, such as the Box-Behnken, central composite, and Doehlert designs, are more often used. However, for two variables, the efficiency is comparable with designs such as central composite. The majority of applications of three-level factorial designs are in the area of chromatography. 2,3,4,5,6.
MATERIAL AND METHODS
Apparatus
A UV-vis Spectrophotometer (Jasco/ v-630), was used with quartz cells of 10mm path length; HPLC (Jasco 12000 series); Column Symmetry C-18, 4.6*250mm, 5µm particle size (Waters); analytical balance (Contech, CB-50 series); ultrasonicator cleaning bath ( spectra lab / UCB-400); filter papers 0.45µm.
Materials
Efavirenz reference standard was obtained as gift sample from Lupin Ltd. Aurangabad, Maharashtra, India and formulation was procured from the market. Ammonium formate buffer of research grade was obtained from Fine chem. Industries Ltd. Mumbai. Acetonitrile of HPLC grade was used for research from Merck Pvt. Ltd. Mumbai.
Stock solution of Efavirenz 1000µg/ml was prepared by using 10mg of Efavirenz in 10ml of methanol.
Chromatographic System
Analysis was carried on Symmetry C-18 4.6*250mm, 5µm particle size column at 292 nm. The samples were introduced through a Rheodyne injector valve with 20-µl sample loop. The mobile phase consisted of acetonitrile and ammonium formate (72:28, v/v), filtered through a membrane filter (0.45µ), degassed in ultrasonic bath, and pumped at a flow rate of 1.0 ml/min. 
RESULTS AND DISCUSSION
Design of Experiment
ANOVA: ANOVA of developed Full three level factorial model for retention time (Y1).
Values of "Prob > F" (p-value) less than 0.0500 indicate model terms are significant. In this case A, B, BC, A 2 and C 2 are significant model terms. 
ANOVA: ANOVA of developed CCD model for tailing factor (Y2).
Values of "Prob > F" (p-value) less than 0.0500 indicate model terms are significant. In this case A, B are significant model terms. For response Y2, factor X1 and X3 was having synergistic effect with p value 0.090 and 0.7054. Therefore we can conclude that increment in amount of ACN and flow rate was responsible for decrease in tailing factor and thus showed the direct relationship between them. Terms X2 were responsible for significant increase in tailing factor with p values -0.0271. Therefore we can conclude that combination of factors showed inverse relationship with response. Factors amount of ACN and combination of flow rate and amount of buffer differs from zero with a great margin therefore they were having more significant effect than other factors.
Effect of independent variables on theoretical plates (Y3):
After applying experimental design, For response Y3, factor pH of buffer was having synergistic effect with p value 0.4460. Therefore we can conclude that increment in pH of buffer was responsible for increment in theoretical plates and thus showed the direct relationship between them.
Combination of amount of ACN and flow rate was responsible for significant increase in theoretical plates with significant p value of 0.0043. Therefore direct relationship between this combination and response is observed. Exponential terms (X 2 2) and (X 2 3) also showed direct relationship with response having significant p values 0.4282 and 0.0030 respectively. Factor pH of buffer and its exponential term differs from zero with a great margin therefore they were having more significant effect than other factors. Therefore it is concluded that pH of buffer and its exponential term was responsible for significant change in response i.e. nos. of theoretical plates. 10, 11,12,13,14.
Analytical Method Development
Different mobile phases were investigated to develop the suitable HPLC method for the analysis of Efavirenz in formulations. For the selection of media the criteria employed was sensitivity of the method, ease of sample preparation, miscibility of the drug, cost of solvents and applicability of method to various purposes. Retention time and peak area of EFV in the selected medium at respective wavelengths were determined and compared with the reference standards and formulation also. 9,10
Chromatogram of Efavirenz Figure 11: A typical chromatogram of Efavirenz
The applied chromatographic conditions permitted a good separation of Efavirenz in a short retention time of 5.642min. (Fig.11) , no drug decomposition was observed during the analysis. The LC method was validated for the parameters reported below.
System suitability study
According to USP, system suitability tests are integral part of liquid chromatographic methods. Retention time, peak area and number of theoretical plates were calculated for standard solutions. The obtained data was found to be within acceptable limits. 
Preparation of Calibration Curve
Stock solution was prepared using 10mg of Efavirenz in 10ml of methanol and further dilutions were done with mobile phase. Solutions were sonicated for 5 min in Ultrasonic clean bath and manually 20µl was injected through the Rheodyne injector. Five concentrations were taken 5-25µg/ml for the calibration curve at 292nm. Linearity graph for Efavirenz is shown in Figure no 12 and Overly spectra of Efavirenz Linearity shown in figure no 13. 6 
Sensitivity
The sensitivity of measurement of EFV by use of the proposed method was estimated in terms of the limit of detection (LOD) and the limit of quantification (LOQ). The LOD and LOQ were calculated by the use of signal to noise ratio. In order to estimate the LOD and LOQ values, the blank sample was injected six times and the peak area of this blank was calculated as noise level. The LOD was calculated as three times the noise level, while ten times the noise value gave the LOQ. LOD and LOQ were found to be 0.126 and 0.420. 9
Accuracy
Accuracy of analytical procedure expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and the value found. This is sometimes termed trueness. Accuracy should be established across the specified range of 98-102 %.
For accuracy three concentrations of five replicates were prepared and injected to get the peak area. Results obtained are shown in 
Mobile Phase
SUMMARY AND CONCLUSION
Determination of Efavirenz by HPLC.
In this project, as per our objective RP-HPLC method was developed by implementing QbD methodology (RSM and 3 level factorial design) on analytical column-reversed phase Waters XBridge C18 (250mm×4.6mm×5μm) with mobile phase Amonium format: Acetonitrile (28:72 v/v). The flow rate used was 1 mL /min and UV detection was carried out at 247 nm. The retention time for Efavirenz was found to be 5.6 min. Before method optimization, screening studies were carried out on different mobile phases, varying composition and pH. Based on the results obtained from these studies, suitable mobile phase with appropriate composition and pH was selected and utilized for method development using QbD methodology.
The RP-HPLC method developed for estimation of Efavirenz was validated as per ICH guidelines using various parameters.
Linearity for the drug by the proposed method was determined to study its ability to elicit test results which are directly proportional to the concentration of analyte in the sample response and was found to be in concentration range 5 to 25 μg/mL (R2 = 0.998).
The limit of detection (LOD) and limit of quantitation (LOQ) was established at a signal-to-noise ratio. LOD and LOQ were calculated as 3.3×δ/S and 10×δ/S respectively as per ICH guidelines, where δ is the standard deviation of the response (y-intercept) and S is the slope of the calibration plot. LOD was found to be 0.126μg/ mL and LOQ was found to 0.420 μg/ mL System suitability test ensures that the analytical system is working properly and can give accurate and precise results. System suitability tests includes resolution, tailing factor, number of theoretical plates, capacity factor etc. The results of all system suitability parameters were acceptable in their limits defined by official guidelines.
The proposed high-performance liquid chromatographic method has also been evaluated over the accuracy, precision and robustness and proved to be convenient and effective for the quality control of Efavirenz. Developed method was found simple and cost effective for the quality control of Efavirenz.
Moreover, the lower solvent consumption along with the short analytical run time of 10.0 min leads to a cost effective and environmentally friendly chromatographic procedure. Thus, the proposed methodology is rapid, selective, requires a simple sample preparation procedure, and represents a good procedure for Efavirenz. 
FUTURE SCOPE
QbD methodology can be applied for Bioanalytical method development and its validation for estimation of EFV.
QbD methodology can be applied for stability indicating studies of EFV.
